Amundi’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17B | Buy |
10,467,411
+1,614,355
| +18% | +$180M | 0.4% | 47 |
|
|
2025
Q1 | $995M | Sell |
8,853,056
-167,143
| -2% | -$18.8M | 0.36% | 54 |
|
|
2024
Q4 | $805M | Sell |
9,020,199
-4,596,188
| -34% | -$410M | 0.28% | 78 |
|
|
2024
Q3 | $1.16B | Buy |
13,616,387
+2,375,858
| +21% | +$202M | 0.43% | 46 |
|
|
2024
Q2 | $751M | Buy |
11,240,529
+1,739,913
| +18% | +$116M | 0.29% | 75 |
|
|
2024
Q1 | $640M | Sell |
9,500,616
-1,019,938
| -10% | -$68.7M | 0.28% | 83 |
|
|
2023
Q4 | $896M | Sell |
10,520,554
-82,104
| -0.8% | -$7M | 0.4% | 47 |
|
|
2023
Q3 | $818M | Sell |
10,602,658
-316,824
| -3% | -$24.4M | 0.4% | 45 |
|
|
2023
Q2 | $838M | Buy |
10,919,482
+294,400
| +3% | +$22.6M | 0.42% | 42 |
|
|
2023
Q1 | $888M | Buy |
10,625,082
+437,302
| +4% | +$36.5M | 0.48% | 38 |
|
|
2022
Q4 | $886M | Sell |
10,187,780
-21,368
| -0.2% | -$1.86M | 0.49% | 35 |
|
|
2022
Q3 | $659M | Buy |
10,209,148
+2,126,205
| +26% | +$137M | 0.39% | 45 |
|
|
2022
Q2 | $500M | Buy |
8,082,943
+1,267,513
| +19% | +$78.4M | 0.4% | 52 |
|
|
2022
Q1 | $412M | Sell |
6,815,430
-4,123,846
| -38% | -$249M | 0.28% | 92 |
|
|
2021
Q4 | $788M | Buy |
10,939,276
+495,760
| +5% | +$35.7M | 0.5% | 39 |
|
|
2021
Q3 | $729M | Buy |
10,443,516
+1,617,865
| +18% | +$113M | 0.51% | 36 |
|
|
2021
Q2 | $608M | Buy |
+8,825,651
| New | +$608M | 0.42% | 47 |
|